跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,016 条关于
“PEXA 2.1”
全部
4,016
临床试验
2,335
药物
1,041
机构
4
资讯
636
上个月
PExA Signs 7.5 MSEK Contract with Top-10 Global Pharma for IPF Clinical Study Using PEXA 2.1 Systems
9个月前
Pfizer Secures $2.1 Billion Deal for YaoPharma's Oral GLP-1 Obesity Drug
去年
Aptevo Therapeutics Secures $2.1 Million in Financing to Advance Immune-Oncology Pipeline
去年
Novartis and Monte Rosa Therapeutics Partner to Advance VAV1 Degrader for Immune-Mediated Conditions
5个月前
Telix and Regeneron Form $2.1 Billion Strategic Partnership to Develop Next-Generation Radiopharmaceuticals
去年
AbbVie Acquires In Vivo CAR-T Developer Capstan Therapeutics for Up to $2.1 Billion
去年
Roche's VENTANA FOLR1 RxDx Assay Receives CE Mark for Ovarian Cancer Treatment Selection
9个月前
Pfizer Secures Exclusive Rights to YaoPharma's Oral GLP-1 Agonist YP05002 in $2.1 Billion Deal
2个月前
UMass Amherst Secures $2.1 Million for Advanced Optical Tweezers and Micro-Patterning Systems to Accelerate Drug Discovery
去年
AbbVie Acquires Capstan Therapeutics for $2.1 Billion to Advance In Vivo CAR-T Technology for Autoimmune Diseases
第 1 页,共 64 页
上一页
下一页